Cell Line : NCI-H660
Cellosaurus Index : CVCL_1576
Cellosaurus ID : NCI-H660
CCLE Name
: NCIH660_PROSTATE
GDSC2 Name
: NCI-H660
CTRP2 Name
: NCIH660
Cancer Type : prostate
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H660 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | 5-Fluorouracil | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H660 | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H660 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | Afatinib | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H660 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AGI-6780 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Alisertib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Alpelisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| NCI-H660 | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | Avagacestat | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Axitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | AZD4547 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AZD5582 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AZD6482 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AZD6738 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | AZD7762 | GDSC2 | 0.0010 | 2.0000 |
|
| NCI-H660 | AZD8186 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BI-2536 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H660 | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Bicalutamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BMS-345541 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | BMS-536924 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | BMS-754807 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| NCI-H660 | Bosutinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H660 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H660 | BRD-K04800985 | CTRP2 | 0.0020 | 67.0000 |
|
| NCI-H660 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| NCI-H660 | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H660 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H660 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | BX795 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H660 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 48.0000 |
|
| NCI-H660 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H660 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | CCT-018159 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | CCT007093 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H660 | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | CHIR-99021 | GDSC2,CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H660 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| NCI-H660 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Crizotinib | GDSC2 | 0.0040 | 8.0000 |
|
| NCI-H660 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H660 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Dabrafenib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| NCI-H660 | Dactolisib | GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H660 | Daporinad | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | Dasatinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H660 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H660 | Dinaciclib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H660 | Docetaxel | GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| NCI-H660 | Doramapimod | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H660 | EHT-1864 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Elesclomol | GDSC2 | 0.0002 | 0.2000 |
|
| NCI-H660 | Entinostat | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Erlotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H660 | Foretinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Fulvestrant | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Gefitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Gemcitabine | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| NCI-H660 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | GSK-J4 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | GSK1904529A | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | GSK269962A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H660 | GW441756 | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H660 | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | I-BET-762 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H660 | IOX2 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H660 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H660 | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | JNK Inhibitor VIII | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H660 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H660 | JQ1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H660 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | KU-55933 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H660 | Lenalidomide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Lestaurtinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H660 | LGK974 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Linsitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H660 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | Methotrexate | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H660 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H660 | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | MK-2206 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H660 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | ML311 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H660 | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Motesanib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| NCI-H660 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Navitoclax | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H660 | Nilotinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | NU7441 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Nutlin-3a | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Olaparib | GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H660 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | OSI-027 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Paclitaxel | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H660 | Palbociclib | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H660 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | PD0325901 | GDSC2 | 0.0025 | 2.5000 |
|
| NCI-H660 | PD173074 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Pevonedistat | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | PF-4708671 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H660 | PFI-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Pictilisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| NCI-H660 | Piperlongumine | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | PLX-4720 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H660 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H660 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H660 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H660 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Rapamycin | GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| NCI-H660 | Refametinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H660 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H660 | RO-3306 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Rucaparib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | Ruxolitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| NCI-H660 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | SB216763 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | SB505124 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | SB590885 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | Selumetinib | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H660 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H660 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H660 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H660 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H660 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H660 | Sepantronium bromide | GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| NCI-H660 | Serdemetan | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | SGC0946 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H660 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | SL0101 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | SN-38 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | SNX-2112 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H660 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H660 | Sorafenib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H660 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Talazoparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Tamoxifen | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Tanespimycin | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Temozolomide | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Temsirolimus | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H660 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | Trametinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H660 | Tretinoin | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H660 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H660 | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| NCI-H660 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| NCI-H660 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Veliparib | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | Venetoclax | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H660 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H660 | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H660 | Vismodegib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Vorinostat | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | VX-680 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | Wee1 Inhibitor | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H660 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | XAV939 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H660 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H660 | YK-4-279 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H660 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| NCI-H660 | ZM447439 | GDSC2 | 0.0100 | 10.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC